share_log

加拿大皇家银行:维持4D Molecular Therapeutics(FDMT.US)评级,由优于大市调整至优于大市评级, 目标价由35.00美元调整至40.00美元。

Zhitong Finance ·  Apr 15 13:35

加拿大皇家银行:维持4D Molecular Therapeutics(FDMT.US)评级,由优于大市调整至优于大市评级, 目标价由35.00美元调整至40.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment